During the past decade, Centre for Tuberculosis Research Innovation, UCT Lung Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre for Tuberculosis Research Innovation, UCT Lung Institute" are "Pulmonary Tuberculosis" (2 trials). Many other conditions were trialed in "Centre for Tuberculosis Research Innovation, UCT Lung Institute" in a lesser frequency.

Most popular intervention types in "Centre for Tuberculosis Research Innovation, UCT Lung Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Rifafour" (2 trials), "Moxifloxacin" (1 trials), "PA-824" (1 trials), "PA-824 (PA)" (1 trials) and "Pyrazinamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre for Tuberculosis Research Innovation, UCT Lung Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centre for Tuberculosis Research Innovation, UCT Lung Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centre for Tuberculosis Research Innovation, UCT Lung Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre for Tuberculosis Research Innovation, UCT Lung Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".